Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Neumann

Showing results (611-620 of 1,206) with videos related to

Pageof 121
Sort By:
Journal of Clinical Microbiology|May 1, 1989
Association of human immunodeficiency virus (HIV) p24 antigenemia with decrease in CD4+ lymphocytes and onset of acquired immunodeficiency syndrome during the early phase of HIV infectionC Rinaldo, L Kingsley, J Neumann, et al.
JAMA Network Open|August 15, 2023
Follow-On Indications for Orphan Drugs Related to the Inflation Reduction ActJames D Chambers, Katherine A Clifford, Daniel E Enright, et al.
Casopis Lekaru Ceskych|March 23, 1973
[Semi-automatic diagnosis of cardiological diseases]V Laufberger, J Neumann, V Novák, et al.
The Journal of Bone and Joint Surgery. American Volume|June 3, 2005
Cost-utility analyses in orthopaedic surgeryCarmen A Brauer, Allison B Rosen, Natalia V Olchanski, et al.
Pharmacoeconomics|April 6, 2004
How often do sensitivity analyses for economic parameters change cost-utility analysis conclusions?Bruce R Schackman, Heather Taffet Gold, Patricia W Stone, et al.
Health Policy (Amsterdam, Netherlands)|February 20, 2013
What can we learn from the U.S. expanded end-stage renal disease bundle?James D Chambers, Daniel E Weiner, Sarah K Bliss, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 12, 2013
Potentially avoidable hospitalizations among Medicare beneficiaries with Alzheimer's disease and related disordersPei-Jung Lin, Howard M Fillit, Joshua T Cohen, et al.
Journal of Managed Care & Specialty Pharmacy|November 28, 2018
Discrepancies Between FDA-Required Labeling and Evidence that Payers Cite in Drug Coverage PoliciesJames D Chambers, Elle F Pope, Colby L Wilkinson, et al.
Journal of the American College of Cardiology|April 13, 2001
Antiplatelet effects of abciximab, tirofiban and eptifibatide in patients undergoing coronary stentingF J Neumann, W Hochholzer, G Pogatsa-Murray, et al.
European Heart Journal|May 1, 1995
Efficacy and safety of collagen implants for haemostasis of the vascular access site after coronary balloon angioplasty and coronary stent implantation. A randomized studyF von Hoch, F J Neumann, W Theiss, et al.
Pageof 121

Showing results (611-620 of 1,206) with videos related to

Sort By:
Pageof 121
Journal of Clinical Microbiology|May 1, 1989
Association of human immunodeficiency virus (HIV) p24 antigenemia with decrease in CD4+ lymphocytes and onset of acquired immunodeficiency syndrome during the early phase of HIV infectionC Rinaldo, L Kingsley, J Neumann, et al.
JAMA Network Open|August 15, 2023
Follow-On Indications for Orphan Drugs Related to the Inflation Reduction ActJames D Chambers, Katherine A Clifford, Daniel E Enright, et al.
Casopis Lekaru Ceskych|March 23, 1973
[Semi-automatic diagnosis of cardiological diseases]V Laufberger, J Neumann, V Novák, et al.
The Journal of Bone and Joint Surgery. American Volume|June 3, 2005
Cost-utility analyses in orthopaedic surgeryCarmen A Brauer, Allison B Rosen, Natalia V Olchanski, et al.
Pharmacoeconomics|April 6, 2004
How often do sensitivity analyses for economic parameters change cost-utility analysis conclusions?Bruce R Schackman, Heather Taffet Gold, Patricia W Stone, et al.
Health Policy (Amsterdam, Netherlands)|February 20, 2013
What can we learn from the U.S. expanded end-stage renal disease bundle?James D Chambers, Daniel E Weiner, Sarah K Bliss, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 12, 2013
Potentially avoidable hospitalizations among Medicare beneficiaries with Alzheimer's disease and related disordersPei-Jung Lin, Howard M Fillit, Joshua T Cohen, et al.
Journal of Managed Care & Specialty Pharmacy|November 28, 2018
Discrepancies Between FDA-Required Labeling and Evidence that Payers Cite in Drug Coverage PoliciesJames D Chambers, Elle F Pope, Colby L Wilkinson, et al.
Journal of the American College of Cardiology|April 13, 2001
Antiplatelet effects of abciximab, tirofiban and eptifibatide in patients undergoing coronary stentingF J Neumann, W Hochholzer, G Pogatsa-Murray, et al.
European Heart Journal|May 1, 1995
Efficacy and safety of collagen implants for haemostasis of the vascular access site after coronary balloon angioplasty and coronary stent implantation. A randomized studyF von Hoch, F J Neumann, W Theiss, et al.
Pageof 121